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Subjects and Methods: 
Subjects were 15 male Sprague-Dawley rats, approximately 4 months old at the beginning of the 
study. Subjects were housed under a reversed 12:12 light:dark cycle with lights off at 1000, with 
water available freely. Subjects were reduced to 85% of their free-feeding weight shortly before 
training began. Subjects were magazine-trained and autoshaped to press the three retractable 
levers before beginning the matching-to-position task. 
Matching-to-Position: 
Sessions ran for 80 trials in operant chambers, as described in figure 2. At the beginning of 
each trial, the stimulus above either the left or right lever is illuminated and that lever is 
extended into the chamber; this is the discriminative stimulus. Two responses on the 
illuminated lever have the effects of extinguishing this light, retracting the lever,  and 
extending, and illuminating the light, over the back wall lever. For the trial to progress, the 
subject must then turn to the back wall lever and press. (This is done to ensure subjects do 
not bridge a delay period by merely remaining in front of the correct lever.) The first 
response after a 1-second delay period leads to the extinguishing of the back light and the 
illumination of both left and right lever lights. 
The subject’s task is now to press the same lever that was illuminated in the first part of the 
trial. Correct responses are rewarded with either a) three sucrose pellets accompanied by 
illumination of the feeder light and a 1 sec train of 8 clicks/second from the clicker (the 
“large” outcome) or b) three 0.5 sec flashes of the feeder light, followed by a single pellet 
(the “small” outcome). For subjects in the DO group (n=8), each stimulus-response 
sequence was consistently followed by a specific outcome (e.g. left-left-small & right-right-
large or left-left-large & right-right-small). For subjects in the NDO group (n=7), outcomes 
were random. Incorrect responses lead to a repeating of the trial; three incorrect 
responses in a row leads to a repeating of the trial, but with only the correct lever 
illuminated at the end of the trial (a forced choice procedure). Only the initial choice on 
each trial is included in overall calculations of accuracy. 
Once subjects learned this task to criterion (3 consecutive days at 85% accuracy or 
above), they were switched to a delayed version of the task, where the delay period 
between the illuminating of the back wall light and the time when the trial could be 
advanced was set to 1, 5,10, or 20 seconds on any given trial. After meeting criterion on 
this task (3 straight days of 85% or above at 1-second delay and 70% or above at 5-sec 
delay), subjects began drug testing. Previous to this set of tests, subjects had been 
exposed to intraperitoneal injections of 0.3 mg/kg and 0.6 scopolamine, 10 mg/kg 
caffeine, 0.3 mg/kg of nicotine, and three saline injections, in the course of other projects. 
Drug Testing: 
Order of drug/control administration was counterbalanced across subjects. Subjects were 
first administered an intraperitoneal injection of dextromethorphan dissolved in saline, at a 
dose of 40 mg/kg, or saline alone, 30 minutes before testing in the delayed-version of the 
task. After an approximately 48-hour interval, the second treatment was administered (e.g. 
if saline was administered on the first testing day, then dextromethorphan was 
administered 48 hours later, or vice versa). 
Results: 
Figures 3A and 3B shows accuracy on testing days as a function of group, delay, and drug condition, for 
DO and NDO groups respectively. For subjects under DO, there was a significant effect of drug, 
F(1,7)=6.667, p=.036, a significant effect of delay, F(3, 21)=6.525, p=.003, and no significant drug x delay 
interaction, F(3,21)=.763, p=.527. For subjects under NDO, there was no significant effect of drug, 
F(1,6)=0, p=1, a significant effect of delay, F(3,18)=11.724, p<.001, and no significant drug x delay effect, 
F(3,18)=.238, p=.869. 
Pairwise Comparisons (Within-Subjects): For the DO group, performance was significantly lower under 


















Figure 3A: accuracy on testing days as a function of group, delay, and drug 






















Figure 3B: accuracy on testing days as a function of group, delay, and drug 




Trapold (1970) found that, in a biconditional discrimination task, subjects who were 
trained with unique and distinct outcomes following each discriminative stimulus-
response (S-R) sequence acquired the task in significantly fewer trials than those 
subjects for whom only one outcome was employed. This training procedure, referred 
to as differential outcomes (DO), is shown in Figure 1, along with the more traditional 
common outcomes (CO) procedure where only one outcome is employed, or a 
nondifferential outcomes (NDO) procedure where two outcomes are employed but the 
outcome presented after each S-R sequence is random. 
This improvement in performance, called the differential outcomes effect (DOE) is also 
seen across delays as an improvement in working memory; that is, subjects trained 
under DO perform with greater accuracy across delays, even at delay intervals where 
subjects trained under CO or NDO are performing at near chance levels. This DOE is 
strong enough to allow subjects to overcome the effects of amnestic drugs and 
lesions designed to mimic the effects of Korsakoff’s syndrome (Savage, 2008). 
The difference in performance may be due to the separate procedures engaging 
different forms of memory. To solve a choice task under CO or NDO, subjects must 
remember the discriminative stimulus presented at the beginning of the trial using 
retrospective memory. However, we theorize that subjects under DO develop 
outcome-specific expectancies of the specific outcomes associated with each 
sample and it is these prospective memories of what is to come (rather than memory 
of what has already happened) that guides behavior on any given trial (Holden and 
Overmier, 2015). These retrospective and prospective codes may well be mediated 
by different memory systems in the brain, dependent on different classes of 
neurotransmitters and different areas of the brain (e.g. frontal lobes and limbic 
system). Our laboratory has conducted a series of pilot studies examining how a 
number of drugs linked to memory influence behavior under DO and NDO in the 
hopes of establishing neurochemical similarities and differences between the two 
systems. 
Dextromethorphan (DXM), as stated by Scholar (2007), is an effective antitussive agent 
for treating uncomplicated, non-productive coughs. DXM is an N-methyl-D-asparatate
receptor (NMDA) antagonist, which when put into effect inhibits the glutamate-
induced excitation and excitotoxicity in the CNS and spinal regions (Scholar, 2007; 
Chez, Kile, Lepage, Parise, Benabides, and Hankins, 2018). In the treatment of coughs, 
the drug is able to suppress the cough reflex by elevating the cough threshold in the 
medulla (Scholar, 2007).  It is available over the counter and has been cited as a safer 
alternative to the cough suppressant codeine due to its production of less 
gastrointestinal disturbances and drug dependence and abuse (Scholar, 2007). 
However, because of its accessibility, drug abusers often mix DXM with drugs like 
heroin and morphine to increase pharmacological effects and decrease their drug 
dependency. In a recent study, evidence of DXM creating a psychological 
dependency was found in 46.5% of drug abusers studied (Ziaee, Hamed, Hoshmand, 
Amini, Kebriaeizadeh, and Saman, 2005). 
Adverse side-effects of DXM include drowsiness, fatigue, dizziness, psychotic reactions, 
slurred speech, and light-headedness. The elderly population are most at risk for 
experiencing these symptoms due to the heavy push of sales of drugs like Neudextra, 
a dextromethorphan and quinidine prescription originally created for the treatment of 
pseudobulbar affect, being expanded to treat symptoms in patients who have 
dementia and Alzheimer’s disease (Ellis & Hicken, 2017). These previous studies and 
side effect evidence make us believe that dextromethorphan would interfere heavily 
with the working memory system when taken. Thus, we hypothesize that 
dextromethorphan would have adverse effect on the memory system, causing a 
significant decrease in task accuracy and differential outcome effects when 
compared to placebo trials. 
Savage (2001) had previously presented evidence suggesting greater involvement of 
glutaminergic NMDA receptors in memory under DO than under NDO using the NMDA 
receptor antagonist MK-801 (dizocilpine). Should this be the case, we should expect to 
see other NMDA receptor antagonists (i.e. dextromethorphan) have stronger effects 
on working memory under DO than under NDO. As such, we hypothesized that DXM 
would significantly impair working memory under DO but not under NDO. 
Figure 1: training procedure for common, nondifferential, 
and differential outcomes
Discussion: 
Our hypothesis was partially confirmed in that performance was significantly 
affected under DO but not under NDO under 2 of the 4 . This supports the 
contention of Savage (2008) that NDO and DO procedures tap different 
memory systems, with the prospective, expectancy based system driving 
behavior under DO being more influenced by NMDA activity. DXM may 
interfere with performance by disrupting the formation of, use of, or proper 
recall of outcome expectancies. Currently we are running a second study with 
the intent of replicating these results. 
